insulin

Johnson & Johnson has issued another recall, and this time, it's not over a typo. The company's Animas unit recalled five lots of leaking insulin cartridges whose use could lead to serious health problems. The 2-milliliter cartridges can leak, resulting in the delivery of less insulin than intended.

Diabetes is a growing global scourge, but for Big Pharma it's more of a lifesaver -- and many drugmakers are cranking up their research efforts. After all, many existing drugs will soon be losing their patents, and diabetes could be a $55 billion market by 2019.

Pharmaceutical giant Eli Lilly -- maker of Prozac and Cialis -- is expected to post solid fourth-quarter profits on Thursday after a recent restructuring. But the results will likely be lower than the year-ago quarter.

Stories about clinical drug trials pop up regularly in the news. Sometimes, that news is good because a novel drug proves itself to be a promising improvement over existing treatments, or even better when it represents a breakthrough against a previously untreatable disease. Of course, drug trials...

Health care reform means more than wonk talk to Jeremiah Hansen Hansen, 28, has no health insurance. He worked for years as a waiter, but the restaurant didn't provide coverage, and he couldn't afford a policy on his own pay as a waiter. Then, in 2007, Hansen was diagnosed with Type 1 diabetes....